U.S. Markets closed

Cytosorbents CEO on flu season

Last year was one of the deadliest flu seasons in decades. According to the CDC over 80,000 people died. And the first deaths have just started being reported, for this flu season. Joining us now Phil Chan, CEO of Cytosorbents -- a biotech focused on blood purification to control deadly inflammations.